GlassScriptPhysician profile
Amanda J Twist
NPI 1720032568
$2,440.50
in general payments reported to CMS, 2019-2025
21 companies · $125 in 2025
The $125 reported for 2025 was less than what a typical Medical provider received nationally (typical 2025 total: $213).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $564 · 2022: $714 · 2023: $692 · 2024: $346 · 2025: $125.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,163.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,163.15 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $719.55 | 2021-2024 | |
| Agile Therapeutics, INC. | $268.42 | 2021-2024 | Twirla |
| Astellas Pharma US INC | $200.20 | 2023-2025 | Veozah, Myrbetriq |
| Pfizer INC. | $165.40 | 2021-2024 | |
| Hologic Sales and Service, LLC | $157.97 | 2021-2025 | Thinprep 2000 Processor, Aptima, Myosure Tissue Removal Device |
| Novo Nordisk INC | $156.32 | 2022-2024 | Wegovy, Saxenda |
| Sumitomo Pharma America, INC. | $151.75 | 2023-2025 | Myfembree |
| Mayne Pharma Commercial LLC | $131.58 | 2021-2025 | |
| Exeltis, USA INC. | $83.93 | 2021-2025 | Slynd |
| Medtronic, INC. | $81.78 | 2021-2022 | |
| Myovant Sciences INC. | $69.44 | 2021-2022 | |
| Coopersurgical, INC. | $60.49 | 2021-2022 | |
| Daiichi Sankyo INC. | $55.26 | 2022 | |
| Biogen, INC. | $21.05 | 2024 | |
| Mylan Pharmaceuticals INC. | $20.31 | 2021 |
Show all 21 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $19.47 | 2023 | Trulance, Xifaxan |
| Becton, Dickinson and Company | $17.11 | 2022 | |
| Stryker Corporation | $16.82 | 2023 | Iris |
| Myriad Women'S Health, INC. | $16.35 | 2023 | Myrisk |
| Merck Sharp & Dohme LLC | $13.97 | 2024 | Gardasil 9, Gardasil |
| Therapeuticsmd, INC. | $13.33 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Amanda Twist listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.